Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Integr Complement Med ; 28(5): 391-398, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35100035

RESUMO

Objective: This pilot study evaluated the effects of Citrus depressa Hayata fruit extract (CFEx) on thigh muscle cross-sectional area (CSA) and composition in subacute stroke patients with hemiparesis who were undergoing rehabilitation. Design and Intervention: This double-blinded, placebo-controlled, randomized pilot trial included 40 subacute stroke patients with moderate-to-severe hemiparesis, and they were randomly assigned to receive CFEx or placebo supplements for 12 weeks. The thigh muscle CSA was measured by computed tomography as total muscle area defined by Hounsfield units (HU) values of -29 to 150 HU. The total muscle area was divided into muscle area with fat infiltration and normal muscle area to evaluate muscle composition (-29 to 29 and 30 to 150 HU, respectively). Results: At baseline, the total muscle area and normal muscle area in the paretic thigh were lower than those in the nonparetic thigh. The nonparetic normal muscle area was significantly higher in the CFEx group than in the placebo group at 12 weeks, whereas the total muscle area was not different. Conclusions: The thigh muscle CSA and composition in the paretic side have already deteriorated in patients with moderate-to-severe hemiparesis at the subacute stroke stage. CFEx supplementation during rehabilitation might improve the nonparetic thigh muscle composition in subacute stroke patients. Findings of this study are needed to be verified by a large-scale randomized trial since this study was a pilot study with a small sample size. Trial registration: UMIN Clinical Trial Registry (UMIN ID: UMIN000012902).


Assuntos
Citrus , Acidente Vascular Cerebral , Frutas , Humanos , Músculo Esquelético/diagnóstico por imagem , Paresia/tratamento farmacológico , Projetos Piloto , Extratos Vegetais/uso terapêutico , Acidente Vascular Cerebral/diagnóstico por imagem , Coxa da Perna
2.
Nutrients ; 10(6)2018 Jun 11.
Artigo em Inglês | MEDLINE | ID: mdl-29891805

RESUMO

Numerous studies have reported that post-exercise ingestion of carbohydrates with protein supplementation can enhance glycogen recovery. However, few reports have focused on the degrees of degradation of the ingested proteins due to post-exercise glycogen resynthesis. Accordingly, the aim of this study was to clarify the effects of differences in protein degradation on muscle glycogen recovery. Male seven-week-old C57BL/6J mice performed a single bout of 60-min treadmill running exercise and were then orally administered glucose (Glu; 1.5 mg/g body weight (BW)), glucose with casein peptide (Glu + Pep; 1.5 + 0.5 mg/g BW) or its constituent amino acid mixture (Glu + AA; 1.5 + 0.5 mg/g BW). At 120 min after supplementation, the soleus muscle glycogen content in the Glu and Glu + AA groups was significantly higher than that immediately after exercise; however, no such difference was observed in the Glu + Pep group. Blood substrate concentration and insulin signaling did not differ among the three groups. Furthermore, energy expenditure during the recovery period in the Glu + Pep group was significantly higher than that in the Glu and Glu + AA groups. These findings suggest that post-exercise co-ingestion of glucose and casein peptide might delay glycogen resynthesis, at least in part through increased energy expenditure caused by casein peptide ingestion.


Assuntos
Caseínas/administração & dosagem , Suplementos Nutricionais , Glucose/administração & dosagem , Glicogênio/metabolismo , Contração Muscular , Músculo Esquelético/efeitos dos fármacos , Esforço Físico , Proteínas Quinases Ativadas por AMP/metabolismo , Animais , Biomarcadores/sangue , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Caseínas/metabolismo , Metabolismo Energético/efeitos dos fármacos , Glucose/metabolismo , Insulina/sangue , Masculino , Camundongos Endogâmicos C57BL , Músculo Esquelético/metabolismo , Fosforilação , Corrida , Fatores de Tempo
3.
Appl Physiol Nutr Metab ; 43(4): 355-362, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29091740

RESUMO

We hypothesized that along with exercise, casein peptide supplementation would have a higher impact on improving glucose tolerance than intact casein. Male 6-week-old ICR mice were provided a high-fat diet to induce obesity and glucose intolerance. The mice were randomly divided into 4 treatment groups: control (Con), endurance training (Tr), endurance training with intact casein supplementation (Cas+Tr), and endurance training with casein peptide supplementation (CP+Tr). The mice in each group were orally administrated water, intact casein, or casein peptide (1.0 mg/g body weight, every day), and then subjected to endurance training (15-25 m/min, 60 min, 5 times/week for 4 weeks) on a motor-driven treadmill 30 min after ingestion. Our results revealed that total intra-abdominal fat was significantly lower in CP+Tr than in Con (p < 0.05). Following an oral glucose tolerance test, the blood glucose area under the curve (AUC) was found to be significantly smaller for CP+Tr than for Con (p < 0.05). Moreover, in the soleus muscle, glucose transporter 4 (GLUT4) protein levels were significantly higher in CP+Tr than in Con (p < 0.01). However, intra-abdominal fat, blood glucose AUC, and GLUT4 protein content in the soleus muscle did not alter in Tr and Cas+Tr when compared with Con. These observations suggest that pre-exercise casein peptide supplementation has a higher effect on improving glucose tolerance than intact casein does in mice fed a high-fat diet.


Assuntos
Glicemia/metabolismo , Caseínas/administração & dosagem , Dieta Hiperlipídica , Suplementos Nutricionais , Intolerância à Glucose/dietoterapia , Fragmentos de Peptídeos/administração & dosagem , Adiposidade , Animais , Biomarcadores/sangue , Modelos Animais de Doenças , Ingestão de Energia , Intolerância à Glucose/sangue , Intolerância à Glucose/etiologia , Intolerância à Glucose/fisiopatologia , Transportador de Glucose Tipo 4/metabolismo , Gordura Intra-Abdominal/metabolismo , Gordura Intra-Abdominal/fisiopatologia , Masculino , Camundongos Endogâmicos ICR , Músculo Esquelético/metabolismo , Obesidade/sangue , Obesidade/fisiopatologia , Fatores de Tempo , Aumento de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA